Explanipedia

Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers Open

Abdessamad El Kaoutari, Nicolás A. Fraunhoffer, Stéphane Audebert, Luc Camoin, Yolande Berthois , et al. · 2023

Fondation ARC (PJA 20181208270 and PGA 12021010002840_3562); INCa; Canceropôle PACA; DGOS; Amidex Foundation; Fondation de France; and INSERM.

Figure S1 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker Open

Christian Bressy, Sophie Lac, Jérémy Nigri, Julie Leca, Julie Roques , et al. · 2023

Measurement of LIF mRNA level in normal and tumoral human fibroblasts by RT-QPCRs.

Supplementary Table S1 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Open

Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques , et al. · 2023

Supplementary Table S1

Supplementary Table S3 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Open

Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques , et al. · 2023

Supplementary Table S3

Supplementary Figure S1 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Open

Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques , et al. · 2023

Supplementary Figure S1

Supplementary Table S2 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Open

Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques , et al. · 2023

Supplementary Table S2

Data from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Open

Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques , et al. · 2023

Purpose:Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a survival rate less than 5%. Multiple chemotherapeutic drugs have been tested to improve patient prognosis; however, the clinical efficacy of these treatments is low.…

Supplementary Table S2 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Open

Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques , et al. · 2023

Supplementary Table S2

Figure S2 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker Open

Christian Bressy, Sophie Lac, Jérémy Nigri, Julie Leca, Julie Roques , et al. · 2023

Schematic representation of experimental protocols for (A) the co-culture method in order to produce specific conditioned media used in following migration assay or ELISA tittering as for (B) the migration assay method for the measurement …

Video S1 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Open

Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques , et al. · 2023

Supplementary Video S1

Video S1 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Open

Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques , et al. · 2023

Supplementary Video S1

Supplementary Figure S3 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Open

Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques , et al. · 2023

Supplementary Figure S3

Data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker Open

Christian Bressy, Sophie Lac, Jérémy Nigri, Julie Leca, Julie Roques , et al. · 2023

Pancreatic ductal adenocarcinoma (PDAC) is characterized by extensive stroma and pathogenic modifications to the peripheral nervous system that elevate metastatic capacity. In this study, we show that the IL6-related stem cell–promoting fa…

Supplementary Figure S2 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Open

Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques , et al. · 2023

Supplementary Figure S2

Figure S1 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker Open

Christian Bressy, Sophie Lac, Jérémy Nigri, Julie Leca, Julie Roques , et al. · 2023

Measurement of LIF mRNA level in normal and tumoral human fibroblasts by RT-QPCRs.

Figure S4 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker Open

Christian Bressy, Sophie Lac, Jérémy Nigri, Julie Leca, Julie Roques , et al. · 2023

We analyzed the impact of LIF (A) or conditioned media (B) on sNF96.2 cell survival using caspase-3 positive cell measurement.